The Value of Post-biopsy Ultrasound in Predicting Complications After Percutaneous Renal Biopsy of Native Kidneys
Overview
Nephrology
Affiliations
Background: Clinically significant bleeding complications occur in >30% of patients undergoing percutaneous renal biopsy (PRB) of native kidneys and can be severe in up to 10% of patients. A noninvasive measure that would reliably predict which patients will do well with an uncomplicated post-biopsy course or which patients may be at risk of developing a clinically significant complication is in great demand.
Methods: PRB of native kidneys was performed in 162 adult patients from February 2002 through February 2007 using real-time ultrasound and automated needle. Renal ultrasound (US) was performed at 1-h post-PRB to assess biopsy-related bleeding. Patients were observed for 24 h post-PRB to monitor clinically apparent biopsy-related complications. The value of the post-biopsy ultrasound in predicting complications was assessed.
Results: A clinically apparent complication was observed in 26 (16%) patients post-PRB (13 minor not requiring any intervention and 13 major requiring intervention). In patients with complicated courses, a haematoma at 1 h was seen in 77% (69% with minor and 87% with major complications). However, only 27 (20%) of 136 patients without complications (P < 0.0001) had a haematoma at 1 h. The presence of a haematoma 1-h post-PRB had a sensitivity of 77%, specificity of 80%, positive predictive value of 43% but a negative predictive value of 95% for predicting clinical complications.
Conclusions: We find that with the use of renal ultrasound 1-h post-PRB, the absence of perinephric bleeding is predictive of an uncomplicated course while the presence of a perinephric haematoma is not reliably predictive of a clinically significant complication post-renal biopsy.
An International Study of Variation in Attitudes to Kidney Biopsy Practice.
Toal M, Hill C, Quinn M, McQuarrie E, ONeill C, Maxwell A Clin J Am Soc Nephrol. 2024; 20(3):377-386.
PMID: 39705236 PMC: 11906007. DOI: 10.2215/CJN.0000000607.
Toal M, Raynor M, McKeaveney C, ONeill C, Quinn M, Hill C PLoS One. 2024; 19(9):e0310358.
PMID: 39259730 PMC: 11389898. DOI: 10.1371/journal.pone.0310358.
Lim C, Khay S World J Nephrol. 2024; 12(5):147-158.
PMID: 38230299 PMC: 10789084. DOI: 10.5527/wjn.v12.i5.147.
Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety.
Schnuelle P J Clin Med. 2023; 12(19).
PMID: 37835066 PMC: 10573674. DOI: 10.3390/jcm12196424.
Safety of Obtaining an Extra Biobank Kidney Biopsy Core.
Bermejo S, Garcia-Carro C, Mast R, Vergara A, Agraz I, Leon J J Clin Med. 2022; 11(5).
PMID: 35268550 PMC: 8911133. DOI: 10.3390/jcm11051459.